January 30, 2023 by Jeffrey Woldt
NASP, National Association of Specialty Pharmacy, Sheila Arquette, Video Forum: Sheila Arquette NASP
Featured Articles, Leading Headlines, Videos
Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy, tells this week’s Video Forum about recent developments in specialty pharmacy. Among the subjects she addresses are what community pharmacies can do to raise their profile in specialty Rx, the importance of coordination across the continuum of care, the impact of biosimilars, and
March 8, 2022 by Chain Drug Review
NASP
Leading Headlines, Pharmacy
WASHINGTON — This week, the National Association of Specialty Pharmacy’s president and CEO Sheila Arquette issued comments that laud the Centers for Medicare and Medicaid Services (CMS) for taking steps to reduce out of pocket drug costs for seniors through initial pharmacy Direct and Indirect Remuneration (DIR) reforms. However, NASP urged CMS to do far more
December 22, 2021 by Chain Drug Review
NASP
Leading Headlines, Pharmacy
WASHINGTON — The National Association of Specialty Pharmacy (NASP) announces the winners of specialty pharmacy’s highly anticipated and coveted scholarship, poster, and specialty pharmacy industry awards. The recipients and winners were announced by Sheila M. Arquette, NASP president & CEO, during a live webinar on December 16, 2021. Though the NASP 2021 Annual Meeting &
November 12, 2021 by Chain Drug Review
NASP
Leading Headlines, Pharmacy
WASHINGTON — As Congress continues to develop and advance budget reconciliation legislation, specialty pharmacies are alarmed that the House has not included pharmacy direct and indirect (DIR) remuneration fee reform. These rising DIR fees under Medicare Part D are harming specialty pharmacies and their patients who are living with life-altering and life-threatening medical conditions. National
May 27, 2021 by Chain Drug Review
NASP, Sheila Arquette
Leading Headlines, Pharmacy
WASHINGTON — This week, a bipartisan group of lawmakers in the U.S. House and Senate introduced legislation to rein in the high cost of prescription drugs and support the needs of specialty pharmacy patients living with life-altering and life-threatening specialty medical conditions. The Pharmacy DIR Reform to Reduce Senior Drug Costs Act will ensure that medication
May 8, 2020 by Chain Drug Review
APhA, ASCP, DIR fees, FMI, NACDS, NASP, NASPA, NCPA
Leading Headlines, Pharmacy
WASHINGTON – More than 240 patient advocates and healthcare entities on Friday urged Congressional leaders to act now on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access for vulnerable Americans. “Members of Congress should not overlook the clear and present opportunity to
March 3, 2020 by Chain Drug Review
2020 Cost of Dispensing Study, NACDS, NASP, NCPA
Leading Headlines, Pharmacy
WASHINGTON – Pharmacy reimbursement paid by state Medicaid programs requires a fresh look and modernization, according to a new Cost of Dispensing Study commissioned by the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and the National Association of Specialty Pharmacy (NASP). DOWNLOAD STUDY DOWNLOAD Q&A In
June 10, 2019 by Chain Drug Review
APhA, DIR Reform, FMI, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, NACDS, NASP, NCPA, NGA
Leading Headlines, Pharmacy
WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to
November 6, 2017 by Chain Drug Review
drug pricing, Hercules Pharmaceuticals, NASP, National Association of Specialty Pharmacy, Onco360, Paul Jardina, Sheila Arquette, specialty pharmacy, Timothy Ward, Tom Suozzi
2017, Issue 11-06-2017, Issues, News
GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) got an education on drug cost dynamics during a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Vice chairman of the Problem Solvers Caucus in the House of Representatives, Suozzi said he made the visit to learn more
October 23, 2017 by Chain Drug Review
Buddy Carter, Centers for Medicare & Medicaid Services, Department of Health and Human Services, DIR fees, Don Wright, Medicare Part D, NASP, National Association of Specialty Pharmacy, Seema Verma, Sheila Arquette, StopDIRfees.com
2017, Issue 10-23-2017, Issues, Opinion
WASHINGTON — The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers. The lawmakers sent a letter to the Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid
October 20, 2017 by CDR Blog and Chain Drug Review
drug pricing, NASP, National Association of Specialty Pharmacy, Onco360, pharmacy industry, prescription drug costs, Tom Suozzi
CDR Blog
No one claims to hold “the solution” to soaring costs for prescription drugs and how Americans and payers — including government — can afford to pay for them. But strides toward unraveling the tangle of problems behind this issue won’t be made without determined attempts at substantive discussion between the public and private sectors, according
October 19, 2017 by Chain Drug Review
DIR fees, Hercules Pharmaceuticals, NASP, National Association of Specialty Pharmacy, Onco360, Paul Jardina, Sheila Arquette, slideshow, specialty drugs, specialty pharmacy, Timothy Ward, Tom Suozzi
Featured Articles, Leading Headlines, Pharmacy, Retail News, Slideshows
GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) gauged cost dynamics of the specialty pharmacy market in a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Seeking insight on what’s driving skyrocketing drug costs and the impact on patients, Suozzi met with Sheila Arquette, executive director
March 10, 2015 by Chain Drug Review
Burt Zweigenhaft, Mike Ellis, NASP, National Association of Specialty Pharmacy, specialty pharmacy
Pharmacy, Retail News
ALEXANDRIA, Va. — The National Association of Specialty Pharmacy (NASP) has relocated its headquarters to the Washington, D.C., area. NASP said Tuesday that the move is effective immediately. The new headquarters address is 1765 Duke St., Alexandria, Va., 22314. NASP staff have already moved to the new location. The association noted that the new location